The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

NCT00421733 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy
Chronic Kidney Disease

Interventions

DRUG: Zemplar (paricalcitol ) capsules
DRUG: Zemplar (paricalcitol) capsules
DRUG: Placebo

Sponsor

Abbott